Columbia Care Florida achieves GMP certification, reinforcing its commitment to quality and safety in medical cannabis manufacturing
Manufacturing facility reports record tolerance specifications of less than 1% active pharmaceutical ingredient (API) variability across initial production batches
ARCADIA, Fla., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Columbia Care LLC, the nation’s leading medical cannabis company, today announced that The British Standards Institution (BSI) has awarded a Good Manufacturing Practice (GMP) certificate to the Columbia Care Florida medical cannabis manufacturing facility, located in Arcadia, in accordance with the Florida Department of Health (DOH) requirements pertaining to the processing, extraction and production of medical cannabis.
The facility also reports tolerance specifications of less than 1% active pharmaceutical ingredient (API) variability across its initial production batches. While the Florida DOH Office of Medical Marijuana Use has not specified variability requirements, the Columbia Care manufacturing facility’s ability to achieve less than 1% API variability is well below the U.S. Food and Drug Administration’s 10% benchmark for API variability for pharmaceutical products sold in the U.S.
“Receiving GMP certification in Florida is a significant milestone for Columbia Care and demonstrates our unwavering national commitment to delivering the highest-quality cannabis-based medicines to our patients, not only throughout Florida but across the country,” said Nicholas Vita, chief executive officer of Columbia Care. “This GMP certification, coupled with less than 1% API variability, is a testament to our dedication to product quality, market leadership and hard-earned reputation for manufacturing the best medical cannabis products in the U.S. We are proud to continue raising the bar for the medical cannabis industry nationally and for patient and provider quality and consistency expectations by bringing superior production standards that surpass even the most stringent regulatory requirements. We are committed to working toward achieving less than 1% active ingredient variability for every production batch across all manufacturing facilities throughout the country.”
About Columbia Care Florida
Columbia Care Florida will initially provide the company’s formulated ClaraCeed™ sublingual tincture, and will expand to include Columbia Care’s proprietary, pharmaceutical-quality ClaraCeed, TheraCeed™ and EleCeed™ medicines in tablet, vaporization, tincture, suppository and topical formats. These precisely-dosed medicines contain a formulated and targeted portfolio of CBD, THC and 10 other functional cannabinoids to maximize effectiveness across a wide range of symptom and illness categories. Columbia Care products begin with an artisanal cultivation process that takes place in the Company’s controlled-environment agricultural production facility in Arcadia, FL. The manufacturing and refinement processes take place in highly controlled labs with trained chemists who follow strict quality control guidelines to ensure product safety and consistency. All products undergo independent batch testing for a variety of measures to ensure the highest levels of purity. Columbia Care offers discounts to veterans, seniors and those on SSDI, Medicaid and Medicare. For more information on Columbia Care Florida and current product offerings, please visit www.col-carefl.com.
About Columbia Care
Columbia Care is the nation’s largest and most experienced manufacturer and provider of medical cannabis products and services. The Company is licensed in highly selective and regulated jurisdictions and has completed more than 750,000 successful patient interactions since its inception. Working in collaboration with some of the most renowned and innovative teaching hospitals and medical centers in the world, Columbia Care is a patient-centered healthcare company setting the standard for compassion, professionalism, quality, caring and innovation for a rapidly expanding new industry. For more information on Columbia Care, please visit www.col-care.com.
Josephine Belluardo, Ph.D.
LifeSci Public Relations
Source: Columbia Care LLC
Released November 6, 2018